Optimizing Fibromyalgia Self-management

March 10, 2017 updated by: Daniel Rooks, Beth Israel Deaconess Medical Center

Short and Long-term Effects of Exercise and Education as Self-management in Women With Fibromyalgia

The overall objective of this work is to improve treatment outcomes for persons with fibromyalgia by optimizing the approach to self-management. The purpose of this research project is to evaluate and compare, in a randomized, controlled trial involving 200 women, the short and long-term effectiveness of four approaches to fibromyalgia self-management for improving health and functional status, self-efficacy, and symptom severity. Additionally, we will also examine the effect of each intervention on health care usage. We will assess the following 16-week interventions:

  • cardiovascular and flexibility exercise
  • strength training, cardiovascular and flexibility exercise
  • Arthritis Foundation's Fibromyalgia Self-Help course
  • a combination of the Fibromyalgia Self-Help Course and strength training exercise interventions

Study Overview

Detailed Description

Fibromyalgia syndrome (FMS) is a common, chronic musculoskeletal disorder and a growing cause of disability and increased health care utilization. Current treatment focuses largely on pharmacological interventions, which are often ineffective at improving symptoms and functional status. Recent research suggests that disease self-management can be efficacious in the short-term at reducing symptom severity and improving function in persons with FMS. The most common forms of FMS self-management are coping skills training (behavioral/education) and exercise. Limited in number, most FMS self-management studies examine the short-term effects of one form or the other, with most using the coping skills training approach. Little data exist to examine the long-term effects of these interventions, the potential additive effect of combining coping skills training with a comprehensive, group exercise program or an approach for promoting long-term compliance of these interventions. The objective of this proposal is to identify the optimal approach to FMS self-management. The study is a randomized, controlled trial comparing coping skills training (the Arthritis Foundation Fibromyalgia Self-Help Course (FSHC)) with two exercise programs - cardiovascular and flexibility training with and without strength training - and a combination (the FSHC plus the strength training exercise program). Each intervention period will last 16 weeks and include group sessions led by trained personnel. Subjects will be followed for 6 months after completing the intervention to evaluate the short-term effect of each program. At 6 months, subjects will be randomized into two groups-one group will receive a 4 week refresher course of their original intervention every 6 months and the other group will receive no further intervention. Long-term follow up will be for 24 months after completing the 16 week intervention period. Subjects will include 200 women (four groups of 50), 25 to 65 years old with a confirmed diagnosis of FMS. Participants will undergo blinded assessment at the Beth Israel Deaconess Medical Center's GCRC at five time points-baseline, completion of the 16-week intervention and 6, 12 and 24 month follow up. We will assess health and functional status (FIQ, SF36), symptom severity (FIQ, SF36, Beck scales), self-efficacy (Arthritis Self-Efficacy Scale), fitness (muscle strength, cardiovascular fitness, flexibility) and health care utilization (direct and indirect costs). The study will improve treatment outcomes for persons with FMS by identifying the optimal self-management program.

Study Type

Interventional

Enrollment (Actual)

207

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Women aged 25 to 75 years of age
  • A confirmed diagnosis of FMS by a primary care physician (and rheumatologist if present) using the American College of Rheumatology criteria
  • Currently under care for their FMS by a primary care physician or rheumatologist
  • Determined to be medically stable by their primary care physician and capable of participation in a supervised program of low to moderate intensity exercise
  • Willingness to commit to time and travel requirements of project

Exclusion Criteria:

  • Do not fulfill ACR definition of FMS
  • Presence of a concurrent condition that limits a person's ability to perform the exercise program (i.e., advanced RA or OA, recent MI)
  • History of a positive exercise/stress test, or current cardiovascular, pulmonary, neurological, or renal disease where an exercise program is contraindicated
  • Uncontrolled hypertension, diabetes, asthma, or heart failure
  • Physician does not want his/her patient to participate for any reason

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Aerobic and flexibility exercise
16 weeks of aerobic and flexibility exercise. Three days per week for 1 hour of walking and cycling.
3x/week of walking and cycling
Experimental: Strength, aerobic, and flexibility
16 weeks of strength training, aerobic, and flexibility exercise (ST) intervention;
3x/week of resistance training activities
Experimental: Fibromyalgia Self-Help Course
7 weeks of FSHC behavior change education
Biweekly group education group meetings
Other Names:
  • Fibromyalgia Self-Help Course
Experimental: a Combination of ST and FSHC
16 wks of a combination of ST and FSHC (ST-FSHC) exercise and behavior change education
3x/week of aerobic and strength training activities

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Fibromyalgia Impact Questionnaire
Time Frame: Baseline, 16 wks and 10 months
Baseline, 16 wks and 10 months

Secondary Outcome Measures

Outcome Measure
Time Frame
SF36 subscales
Time Frame: Baseline, 16 wks and 10 months
Baseline, 16 wks and 10 months
Beck Depression Inventory
Time Frame: Baseline, 16 wks and 10 months
Baseline, 16 wks and 10 months
Beck Anxiety Inventory
Time Frame: Baseline, 16 wks and 10 months
Baseline, 16 wks and 10 months
6 minute Walk Test
Time Frame: Baseline, 16 wks and 10 months
Baseline, 16 wks and 10 months
1 Repetition Maximum Chest Press
Time Frame: Baseline, 16 wks and 10 months
Baseline, 16 wks and 10 months
1 Repetition Maximum Leg Press
Time Frame: Baseline, 16 wks and 10 months
Baseline, 16 wks and 10 months
Self Efficacy Scale
Time Frame: Baseline, 16 wks and 10 months
Baseline, 16 wks and 10 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Daniel S. Rooks, PhD, Beth Israel Deaconess Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 10, 2002

Primary Completion (Actual)

September 21, 2005

Study Completion (Actual)

September 21, 2005

Study Registration Dates

First Submitted

May 3, 2006

First Submitted That Met QC Criteria

May 3, 2006

First Posted (Estimate)

May 4, 2006

Study Record Updates

Last Update Posted (Actual)

March 14, 2017

Last Update Submitted That Met QC Criteria

March 10, 2017

Last Verified

March 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No plan was prepared, as no data was to be shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fibromyalgia

Clinical Trials on Aerobic

3
Subscribe